Only use certain shots free of an ingredient antivaccine groups have falsely tied to autism, the advisers said.

The company has awarded 40+ startups globally through Advance Biotech Grant since 2014 BURLINGTON, Mass.-- (BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, ...

Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.

Merck (NYSE:MRK) recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastatic castration ...

Merck KGaA (ETR:MRK) has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could ...

Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.

Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare ConferenceRAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages ...

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus, which was in short supply nationwide during the 2023 RSV season due to unprecedented ...